Moderna Inc (MRNA) Stock Price, Quote & News

Company Profile

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 714 6500

Website: www.modernatx.com

Address:

325 Binney Street, Cambridge, United States

TonyScar Feb. 3 at 11:54 PM

$MRNA a 40% pop on earnings will be decent

0 · Reply

taxplanr Feb. 3 at 10:50 PM

So the Epstein files show Bill Gates and Jeffrey Epstein planning the COVID pandemic in 2017 $MRNA $BNTX $PFE $NVAX https://www.instagram.com/reel/DUTrmJ4j5WU/?igsh=bGR3aXllZW0waDUx

1 · Reply

sister Feb. 3 at 10:26 PM

$MRNA can always buy cheaper . . . $PFE and $NVO lowr too

0 · Reply

Cris0 Feb. 3 at 9:28 PM

$MRNA Gold 100+ soon $SPY

0 · Reply

Goldmine0 Feb. 3 at 8:40 PM

$MRNA $SPY

0 · Reply

whiteboytrippin Feb. 3 at 8:19 PM

$MRNA Pain, loss and failures don’t bother me.

0 · Reply

Goldmine0 Feb. 3 at 8:07 PM

$MRNA 60 soon BUY

0 · Reply

CapitalismUSA Feb. 3 at 7:56 PM

$MRNA If you are a Moderna investor you better understand what is at risk given the upcoming Arbutus Bio patent infringement trial. I’ll give you one clue….EVERYTHING

0 · Reply

10xby3 Feb. 3 at 7:17 PM

$MRNA LODL AND HODL

0 · Reply

Cris0 Feb. 3 at 6:26 PM

$MRNA What the actual fuck

0 · Reply

Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today?

NVAX

Jan 30, 2026, 9:06 AM EST - 4 days ago

Moderna CMO Jacqueline Miller to step down

Jan 30, 2026, 7:30 AM EST - 4 days ago

Dr. David Berman to Join Moderna as Chief Development Officer

Jan 29, 2026, 5:20 PM EST - 5 days ago

RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA

Jan 29, 2026, 5:00 PM EST - 5 days ago

Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)

Jan 26, 2026, 7:00 AM EST - 8 days ago

Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026

Jan 22, 2026, 10:09 PM EST - 11 days ago

MRNY: Jumping On Big Moderna Move

Jan 22, 2026, 5:22 PM EST - 12 days ago

Baseline characteristics in Moderna cancer vaccine 'misleading': Leerink's Dr. Mani Foroohar

Jan 22, 2026, 11:20 AM EST - 12 days ago

Moderna is curbing investment in vaccine trials due to US backlash

Jan 22, 2026, 11:08 AM EST - 12 days ago

Moderna curbing investments in vaccine trials due to US backlash, CEO tells Bloomberg TV

Jan 22, 2026, 11:00 AM EST - 12 days ago

MRNA Rallies on Cancer Vaccine Trial, PG Mixed Earnings, ABT Sell-Off

ABT PG

Jan 22, 2026, 10:08 AM EST - 12 days ago

Moderna CEO Says Vaccine Scrutiny Is Curbing Trials

Jan 22, 2026, 9:15 AM EST - 12 days ago

MRNA Stock: Why 16% Pop May Signal More Upside

Jan 22, 2026, 9:15 AM EST - 12 days ago

What's Happening With Moderna Stock?

Jan 22, 2026, 6:27 AM EST - 12 days ago

Moderna Stock Is Surging. Why a Cancer Vaccine Study Has Sparked a Rally.

Jan 22, 2026, 5:19 AM EST - 12 days ago

Stock Market Today: S&P 500, Dow Jones Futures Rise As Trump Scales Down EU Tariff Threats—Microsoft, Moderna, Intel In Focus

INTC IVV SPXL SPY SSO UPRO VOO

Jan 20, 2026, 6:58 AM EST - 14 days ago

Moderna, Merck Report Positive Results From Cancer-Vaccine Study

MRK

Jan 20, 2026, 6:25 AM EST - 14 days ago

Moderna, Merck's skin cancer vaccine shows sustained benefit after five years

MRK

Jan 20, 2026, 6:00 AM EST - 14 days ago

Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection

MRK

Jan 13, 2026, 8:15 AM EST - 21 days ago

Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story

Jan 12, 2026, 10:26 PM EST - 21 days ago

Moderna, Inc. (MRNA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 8:51 AM EST - 22 days ago

Moderna Stock Rises. Revenue in 2025 Will Be Higher Than Midpoint of Guidance.

Jan 12, 2026, 7:12 AM EST - 22 days ago

Moderna expects $1.9 billion in sales, trims costs forecast for 2025

Jan 12, 2026, 7:00 AM EST - 22 days ago

Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 9:03 AM EST - 27 days ago

Moderna Stock Fights Back Against Four‑Year Curse With 20% Blastoff And A Golden Cross

Jan 6, 2026, 11:55 AM EST - 4 weeks ago

America's new vaccine doctrine for children replaces data with dogma

PFE

Jan 5, 2026, 7:00 AM EST - 4 weeks ago

Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine

Dec 18, 2025, 7:02 AM EST - 6 weeks ago

Moderna secures up to $54.3 million funding for bird flu vaccine from global coalition

Dec 18, 2025, 7:00 AM EST - 6 weeks ago

CEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate

Dec 17, 2025, 7:00 AM EST - 6 weeks ago

Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 15, 2025, 7:00 AM EST - 7 weeks ago

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)

Dec 2, 2025, 1:33 PM EST - 2 months ago

Moderna, Inc. (MRNA) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Dec 1, 2025, 4:50 PM EST - 2 months ago

S&P 500 Gains and Losses Today: Moderna Falls; Synopsys Stock Climbs on Nvidia Partnership

SNPS

Dec 1, 2025, 3:50 PM EST - 2 months ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX NVAX PFE

Dec 1, 2025, 12:50 PM EST - 2 months ago

Top Stock Movers Now: Coinbase, Robinhood, Moderna, Synopsys, and More

COIN HOOD SNPS

Dec 1, 2025, 12:35 PM EST - 2 months ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX NVAX PFE

Dec 1, 2025, 9:59 AM EST - 2 months ago

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

NVAX

Nov 24, 2025, 8:03 PM EST - 2 months ago

Moderna, Inc. (MRNA) Analyst/Investor Day Transcript

Nov 20, 2025, 7:03 AM EST - 2 months ago

Moderna takes $1.5 billion loan, expects 10% revenue growth next year

Nov 20, 2025, 7:00 AM EST - 2 months ago

Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management

Nov 20, 2025, 7:00 AM EST - 2 months ago

Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates

Nov 19, 2025, 8:44 AM EST - 2 months ago

Moderna to complete US mRNA manufacturing network with $140 million investment

Nov 19, 2025, 7:00 AM EST - 2 months ago

Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities

Nov 18, 2025, 7:00 AM EST - 2 months ago

Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025

Nov 13, 2025, 9:25 AM EST - 2 months ago

What Is Going On With Moderna Stock?

Nov 6, 2025, 3:26 PM EST - 3 months ago

Moderna, Inc. (MRNA) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 12:29 PM EST - 3 months ago

mRNA Vaccine Maker Moderna Lowers R&D Spending, Tightens Sales Forecast

Nov 6, 2025, 7:11 AM EST - 3 months ago

Moderna trims top end of full-year forecast on weak COVID vaccine sales

Nov 6, 2025, 7:09 AM EST - 3 months ago

Moderna Swings to a Loss on Fewer Covid-19 Vaccine Sales

Nov 6, 2025, 7:00 AM EST - 3 months ago

Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates

TonyScar Feb. 3 at 11:54 PM

$MRNA a 40% pop on earnings will be decent

0 · Reply

taxplanr Feb. 3 at 10:50 PM

So the Epstein files show Bill Gates and Jeffrey Epstein planning the COVID pandemic in 2017 $MRNA $BNTX $PFE $NVAX https://www.instagram.com/reel/DUTrmJ4j5WU/?igsh=bGR3aXllZW0waDUx

1 · Reply

sister Feb. 3 at 10:26 PM

$MRNA can always buy cheaper . . . $PFE and $NVO lowr too

0 · Reply

Cris0 Feb. 3 at 9:28 PM

$MRNA Gold 100+ soon $SPY

0 · Reply

Goldmine0 Feb. 3 at 8:40 PM

$MRNA $SPY

0 · Reply

whiteboytrippin Feb. 3 at 8:19 PM

$MRNA Pain, loss and failures don’t bother me.

0 · Reply

Goldmine0 Feb. 3 at 8:07 PM

$MRNA 60 soon BUY

0 · Reply

CapitalismUSA Feb. 3 at 7:56 PM

$MRNA If you are a Moderna investor you better understand what is at risk given the upcoming Arbutus Bio patent infringement trial. I’ll give you one clue….EVERYTHING

0 · Reply

10xby3 Feb. 3 at 7:17 PM

$MRNA LODL AND HODL

0 · Reply

Cris0 Feb. 3 at 6:26 PM

$MRNA What the actual fuck

0 · Reply

pfh_investing Feb. 3 at 6:13 PM

$MRNA what just happened? News?

1 · Reply

pfh_investing Feb. 3 at 6:10 PM

$MRNA damn quite the mid day drop

0 · Reply

foghornL Feb. 3 at 6:01 PM

$DJT $PFE $MRNA Health Canada seals COVID vaccine injury files for 15 years An Order Paper response confirms millions of pages on vaccine and adverse drug reactions are sealed until the 2040s, echoing the U.S. FDA’s attempt to hide Pfizer’s trial data for 75 years.

0 · Reply

Thepatientone Feb. 3 at 5:52 PM

$ABUS - No body wants out. The SJ was a win in every aspect. Weather this short term volatility and you will be on top. ABUS long and strong. 12-15 percent rate - I have said it all along. $MRNA hostile takeover target.

2 · Reply

LadsAndGents Feb. 3 at 4:43 PM

$MRNA regain 46 point buddy .. don’t sell you at 54 be nice to me

0 · Reply

Ren_Stimpy Feb. 3 at 4:31 PM

Can the bio-nerds from $ALLO $ATON $PGEN $MRNA tell me why $HURA is so hated? Can't find the red flags. What am I missing? https://ir.tuhurabio.com/news-events/presentations

0 · Reply

WhosYourDaddy_ Feb. 3 at 4:28 PM

$NVAX The good news is $MRNA is up over 3% again

0 · Reply

cbroth1 Feb. 3 at 4:06 PM

$MRNA a lot of firepower be thrown at this to stop every run.

0 · Reply

Mibl Feb. 3 at 3:44 PM

$MRNA seems to be up a bit due to $MRK earnings. CEO happy with partnership and many more drugs in the pipeline for these two. Imho these 2 could build an oncology portfolio full of blockbusters if results are as good as everyone hopes.

1 · Reply

free2dream Feb. 3 at 3:38 PM

$SRPT Sarepta is being accumulated around $20 give or take. Exactly same as the most hated $MRNA in the $20S just to pop to mid $50S. Give it time, single upgrade or the earnings ramp up will make it gap up to mid $50S. This will be the best trade in 2026. $XBI

0 · Reply

Thepatientone Feb. 3 at 3:19 PM

$ABUS - These look to be options so hold tight. ABUS long and Strong and $MRNA will loose dearly...

1 · Reply

Goldmine0 Feb. 3 at 3:14 PM

$MRNA Let's break 50

0 · Reply

Market Cap	17.22B
Revenue (ttm)	3.24B
Net Income (ttm)	-3.56B
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-110.04%
Debt to Equity Ratio	0.00

Volume	9,368,000
Avg Vol	12,079,642
Day's Range	N/A - N/A
Shares Out	390.73M
Stochastic %K	7%
Beta	1.17
Analysts	Hold
Price Target	$37.40